Announcement on Earnings Preannouncement for 2025
Filed with SSE · · 2 pages · Chinese
Shenzhen Chipscreen Biosciences Co. Ltd. on 6ix
Earlier from Shenzhen Chipscreen Biosciences
- Indicative Announcement on "Chipscreen Convertible Bonds" Expected to Meet Conditions for Redemption
- Announcement on Estimated Amount of Daily Related Party Transactions in 2026
- Prospectus for Issuance of A-shares to Specific Objects in 2024 (Registration Draft)
- Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Clinical Trials of Chiauranib Capsules
- Announcement on Voluntary Disclosure of Approval of Chidamide for Market Release by the Pharmaceutical Administration Bureau, Macao SAR
Later from Shenzhen Chipscreen Biosciences
- Announcement on Proposed Participation of Connected Persons in the Subscription of Shares Issued to Specific Objects and Related Party Transaction
- Announcement on the Thawing of Partially Frozen Shares Held by a Shareholder Owning 5% or More of the Company’s Equity
- Announcement on Execution of a License and Distribution Agreement with Nizhpharm
- Announcement on Signing Tripartite Supervision Agreement for Deposit of Raised Fund in Special Account
- Announcement on Preliminary Earnings Estimate for 2025
Follow Shenzhen Chipscreen Biosciences into a list and get an email when it puts out news.
Follow Shenzhen Chipscreen Biosciences